Results 281 to 290 of about 648,509 (314)

Harnessing Next‐Generation 3D Cancer Models to Elucidate Tumor‐Microbiome Crosstalk

Advanced Healthcare Materials, EarlyView.
Centralizes the microbiome within 3D tumor‐microbiome model platforms, including spheroids, organoids, 3D‐bioprinted constructs, and microfluidic chips, each enabling structured host‐tumor‐microbe studies. These systems support bacterial colonization, facilitating investigation of microbial impacts on tumor growth, immunity, and therapy. The microbiome
Marina Green Buzhor, Giuseppe Longobardi, Or Kandli, Anne Krinsky, Opal Avramoff, Anshika Katyal, Koren Salomon, Adan Miari, Dana Venkert, Tania T. Barnatan, América García Alvarado, Shahar Greenberg, Ronit Satchi‐Fainaro   +12 more
wiley   +1 more source

Trastuzumab Deruxtecan Significantly Reduces Human Epidermal Growth Factor Receptor 2-Positive Pancreatic Metastasis from Advanced Breast Cancer: A Case Report. [PDF]

Surg Case Rep
Tanida R, Tanaka T, Hamada-Nishimoto M, Senda N, Kang Y, Shiozaki T, Fujii H, Sakurai T, Tsuyuki S.   +8 more
europepmc   +1 more source

Microphysiological Systems of Lymphatics and Immune Organs

Advanced Healthcare Materials, EarlyView.
This review surveys recent progress in engineering lymphatic microenvironments and immune organoids within microphysiological systems, emphasizing innovative strategies to recreate the biochemical and biophysical complexity of native lymphatic tissues.
Ishita Jain, Ankur Singh, Andrés J. García   +2 more
wiley   +1 more source

Progressive Insights into 3D Bioprinting for Corneal Tissue Restoration

Advanced Healthcare Materials, EarlyView.
This review explores the potential of 3D bioprinting to replicate the complex structure and function of the human cornea. It highlights key advances in bioink development, printing modalities, and in vivo performance, while addressing current challenges and emerging strategies. The review emphasizes bioprinting's promise to overcome donor shortages and
Ilayda Namli, Deepak Gupta, Yogendra Pratap Singh, Pallab Datta, Muhammad Rizwan, Mehmet Baykara, Ibrahim T. Ozbolat   +6 more
wiley   +1 more source

A momentous progress update: epidermal growth factor receptor inhibitors as viable agents for combating cancer. [PDF]

RSC Med Chem
Jangra N, Sharma B, Kumar D, Kapoor A.
europepmc   +1 more source

Predicting Human Epidermal Growth Factor Receptor 2 Expression in Breast Cancer Based on Radiomics of MRI Habitat and US. [PDF]

Breast Cancer (Dove Med Press)
Lin Z, Huang F, Wei L, Liao X, Gao Y.
europepmc   +1 more source

Correction: Exploring the role of epidermal growth factor receptor variant III in meningeal tumors. [PDF]

PLoS One
Rana R, Rathi V, Chauhan K, Jain K, Chhabra SS, Acharya R, Kalra SK, Gupta A, Jain S, Ganguly NK, Yadav DK.   +10 more
europepmc   +1 more source

Mapping O-Fucosylation and O-Glucosylation on Human Notch3 Epidermal Growth Factor-Like (EGF) Repeats Using Nano-LC-ESI-MS/MS

, 2012
Ga‐Ram Hwang
openalex   +1 more source

Human epidermal growth factor receptor-2, nectin-4, and trophoblast cell surface antigen-2 expression in endometrial carcinosarcoma. [PDF]

Gynecol Oncol Rep
Lin SY, Chang CT, Wu RC, Lai CR, Chen YJ.   +4 more
europepmc   +1 more source

Effect of prenatal heparin-binding epidermal growth factor (HB-EGF) administration on necrotizing enterocolitis-induced lung injury in a murine model. [PDF]

World J Pediatr Surg
Giang B, Radulescu A, Mladenov GD, Wilson CG.   +3 more
europepmc   +1 more source